Quinazoline compounds and their use in therapy
US9932317B2 · kind B2 · utility
0Cited by
3References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 19, 2013 |
| Grant date | Apr 3, 2018 |
| Priority date | — |
| Expiry date | Mar 19, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/056
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to quinazoline compounds of Formula (I) which are inhibitors of the histone lysine methyltransferase (HKMTase) EZH2, and to uses of such compounds as medicaments, in particular in the treatment of a disease or disorder in which inhibition of EZH2 provides a therapeutic or prophylactic effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.